Lymphatic filariasis overview: Difference between revisions
No edit summary |
|||
| Line 29: | Line 29: | ||
==Treatment== | ==Treatment== | ||
===Medical Therapy=== | |||
People infected with adult worms can take a yearly dose of [[medicine]], called [[diethylcarbamazine]] (DEC), that kills the microscopic worms circulating in the blood. While this drug does not kill all of the adult [[worms]], it does prevent infected people from giving the [[disease]] to someone else. [[Lymphedema]] and elephantiasis are not indications for DEC treatment because most people with [[lymphedema]] are not actively infected with the filarial parasite. Physicians can obtain DEC from CDC after lab results confirm [[infection]]. | |||
== References == | == References == | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 16:23, 28 December 2012
|
Lymphatic filariasis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphatic filariasis overview On the Web |
|
American Roentgen Ray Society Images of Lymphatic filariasis overview |
|
Risk calculators and risk factors for Lymphatic filariasis overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]
Overview
Lymphatic filariasis, considered globally as a Neglected Tropical Disease, is a parasitic disease caused by microscopic, thread-like worms. The adult worms only live in the human lymph system. The lymph system maintains the body's fluid balance and fights infections. Lymphatic filariasis is spread from person to person by mosquitoes. People with the disease can suffer from lymphedema and elephantiasis and in men, swelling of the scrotum, called hydrocele. Lymphatic filariasis is a leading cause of permanent disability worldwide. Communities frequently shun and reject women and men disfigured by the disease. Affected people frequently are unable to work because of their disability, and this harms their families and their communities.
Historical Perspective
Lymphatic Filariasis is thought to have affected humans since approximately 1500-4000 years ago and the first documentation of symptoms occurred in the 16th century, when Jan Huygen Linschoten wrote about the disease during the exploration of Goa.
Pathophysiology
Infective larvae are transmitted by infected biting mosquitoes during a blood meal. The larvae migrate to lymphatic vessels and lymph nodes, where they develop into microfilariae-producing adults. The adults dwell in lymphatic vessels and lymph nodes where they can live for several years. The female worms produce microfilariae which circulate in the blood. The microfilariae infect biting mosquitoes. Inside the mosquito, the microfilariae develop in 1 to 2 weeks into infective filariform (third-stage) larvae. During a subsequent blood meal by the mosquito, the larvae infect the vertebrate host. They migrate to the lymphatic vessels and lymph nodes of the human host, where they develop into adults.
Causes
Lymphatic Filariasis is caused by nematodes (roundworms) that inhabit the lymphatic vessels and lymph nodes of a human host. Wuchereria bancrofti, Brugia malayi and Brugia timori cause lymphatic filariasis.
Risk Factors
Repeated mosquito bites over several months to years are needed to get lymphatic filariasis. People living for a long time in tropical or sub-tropical areas where the disease is common are at the greatest risk for infection. Short-term tourists have a very low risk.
Diagnosis
History and Symptoms
Most infected people are asymptomatic and will never develop clinical symptoms, despite the fact that the parasite damages the lymph system. A small percentage of persons will develop lymphedema. Filarial infection can also cause pulmonary tropical eosinophilia syndrome. Most people develop these clinical manifestations years after being infected.
Treatment
Medical Therapy
People infected with adult worms can take a yearly dose of medicine, called diethylcarbamazine (DEC), that kills the microscopic worms circulating in the blood. While this drug does not kill all of the adult worms, it does prevent infected people from giving the disease to someone else. Lymphedema and elephantiasis are not indications for DEC treatment because most people with lymphedema are not actively infected with the filarial parasite. Physicians can obtain DEC from CDC after lab results confirm infection.